Epa Drug Initiative II
General
Total Cases2
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 07/14/22 | RECEIPT for Exhibits released to Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited on 7/14/2022. (KF) (Entered: 07/14/2022) | |
| 07/13/22 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 7/13/2022. By Deputy Clerk: Peggie Vannozzi. The court currently has custody of exhibits in this action in its Reno division. It has been determined these exhibits can be returned to the parties. IT IS ORDERED that the parties have 21 days from the date of this order to claim the exhibits from the clerk under Local Rule 79-1 or exhibits shall be destroyed. Please contact the Clerk's Office in Reno at (775) 686-5800 to make arrangements to have the exhibits picked up or said exhibits shall be destroyed by the court. Deadline to return exhibits set for 8/3/2022. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 07/13/2022) | |
| 03/29/22 | ORDER on Mandate as to 413 Notice of Appeal, filed by EPA Drug Initiative II. Signed by Chief Judge Miranda M. Du on 3/29/2022. (Copies have been distributed pursuant to the NEF - LG) (Entered: 03/29/2022) | |
| 03/24/22 | MANDATE of USCA, Federal Circuit, as to ECF No. 417 USCA Judgment affirming USDC. USCA Fed. Ckt. Case No. 21-2024. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/24/2022) | |
| 02/15/22 | JUDGMENT of USCA, Federal Circuit, as to ECF No. 413 Notice of Appeal. USDC AFFIRMED. Mandate to issue in due course. USCA Fed. Ckt. Case No. 21-2024. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 02/15/2022) | |
| 06/08/21 | USCA, Federal Circuit Appellate Case Number 2021-2024 assigned to [413] Notice of Appeal,. (DRS) | |
| 06/07/21 | TRANSCRIPT DESIGNATION by Intervenor Plaintiff EPA Drug Initiative II re [413] Notice of Appeal,. Transcripts are NOT required for this appeal. (Kasanoff, Michael) | |
| 05/21/21 | FORMS - Designation of Transcripts and Transcript Order forms and instructions for ECF No. [413] Notice of Appeal. Forms may also be obtained on the Court's website at www.nvd.uscourts.gov. (Attachments: # [1] Transcript Order Form) (KR) | |
| 05/20/21 | NOTICE OF APPEAL as to [412] Order on Motion to Intervene, Order on Motion to Vacate,, by Intervenor Plaintiff EPA Drug Initiative II. Filing fee $ 505, receipt number 0978-6494996. E-mail notice (NEF) sent to the Federal Circuit Court of Appeals. (Kasanoff, Michael) | |
| 04/30/21 | ORDERED that EPA Drug Initiative II's motion to intervene (ECF No. [401] ) is denied. It is further ordered that EPA Drug Initiative II's motion to vacate (ECF No. [405] ) is denied. Signed by Chief Judge Miranda M. Du on 4/30/2021. (Copies have been distributed pursuant to the NEF - DRM) |